keyword
MENU ▼
Read by QxMD icon Read
search

numb ovarian cancer

keyword
https://www.readbyqxmd.com/read/27397040/toxicity-and-quality-of-life-after-adjuvant-chemoradiotherapy-versus-radiotherapy-alone-for-women-with-high-risk-endometrial-cancer-portec-3-an-open-label-multicentre-randomised-phase-3-trial
#1
Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, Marie-Helene Baron, Henry C Kitchener, Hans W Nijman, Roy F Kruitwagen, Remi A Nout, Karen W Verhoeven-Adema, Vincent T Smit, Hein Putter, Carien L Creutzberg
BACKGROUND: About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial cancer-related death. We designed the PORTEC-3 trial to investigate the benefit of adjuvant chemoradiotherapy compared with radiotherapy alone for women with high-risk endometrial cancer. METHODS: PORTEC-3 was a multicentre, open-label, randomised, international trial. Women with high-risk endometrial cancer were randomly allocated (1:1) to radiotherapy alone (48·6 Gy) in 1·8 Gy fractions five times a week or chemoradiotherapy (two cycles concurrent cisplatin 50 mg/m(2) and four adjuvant cycles of carboplatin area under the curve [AUC] 5 and paclitaxel 175 mg/m(2)) using a biased coin minimisation procedure with stratification for participating centre, lymphadenectomy, stage of cancer, and histological type...
August 2016: Lancet Oncology
https://www.readbyqxmd.com/read/27183099/the-association-of-chemotherapy-induced-peripheral-neuropathy-symptoms-and-the-risk-of-falling
#2
Noah A Kolb, A Gordon Smith, J Robinson Singleton, Susan L Beck, Gregory J Stoddard, Summer Brown, Kathi Mooney
IMPORTANCE: Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of neurotoxic chemotherapy resulting in pain, sensory loss, and decreased quality of life. Few studies have prospectively examined the relationship between sensory neuropathy symptoms, falls, and fall-related injuries for patients receiving neurotoxic chemotherapy. OBJECTIVE: To determine the association between the symptoms of CIPN and the risk of falls for patients receiving neurotoxic chemotherapy...
July 1, 2016: JAMA Neurology
https://www.readbyqxmd.com/read/26746209/nausea-as-a-sentinel-symptom-for-cytotoxic-chemotherapy-effects-on-the-gut-brain-axis-among-women-receiving-treatment-for-recurrent-ovarian-cancer-an-exploratory-analysis
#3
Heidi S Donovan, Teresa L Hagan, Grace B Campbell, Michelle M Boisen, Leah M Rosenblum, Robert P Edwards, Dana H Bovbjerg, Charles C Horn
PURPOSE: Nausea is a common and potentially serious effect of cytotoxic chemotherapy for recurrent ovarian cancer and may function as a sentinel symptom reflecting adverse effects on the gut-brain axis (GBA) more generally, but research is scant. As a first exploratory test of this GBA hypothesis, we compared women reporting nausea to women not reporting nausea with regard to the severity of other commonly reported symptoms in this patient population. METHODS: A secondary analysis of data systematically collected from women in active chemotherapy treatment for recurrent ovarian cancer (n = 158) was conducted...
June 2016: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/26523864/cancer-mediates-effector-t-cell-dysfunction-by-targeting-micrornas-and-ezh2-via-glycolysis-restriction
#4
Ende Zhao, Tomasz Maj, Ilona Kryczek, Wei Li, Ke Wu, Lili Zhao, Shuang Wei, Joel Crespo, Shanshan Wan, Linda Vatan, Wojciech Szeliga, Irene Shao, Yin Wang, Yan Liu, Sooryanarayana Varambally, Arul M Chinnaiyan, Theodore H Welling, Victor Marquez, Jan Kotarski, Hongbo Wang, Zehua Wang, Yi Zhang, Rebecca Liu, Guobin Wang, Weiping Zou
Aerobic glycolysis regulates T cell function. However, whether and how primary cancer alters T cell glycolytic metabolism and affects tumor immunity in cancer patients remains a question. Here we found that ovarian cancers imposed glucose restriction on T cells and dampened their function via maintaining high expression of microRNAs miR-101 and miR-26a, which constrained expression of the methyltransferase EZH2. EZH2 activated the Notch pathway by suppressing Notch repressors Numb and Fbxw7 via trimethylation of histone H3 at Lys27 and, consequently, stimulated T cell polyfunctional cytokine expression and promoted their survival via Bcl-2 signaling...
January 2016: Nature Immunology
https://www.readbyqxmd.com/read/26514517/treatment-outcomes-of-epithelial-ovarian-cancers-following-maximum-cytoreduction-and-adjuvant-paclitaxel-carboplatin-chemotherapy-egyptian-nci-experience
#5
Hanan Ramadan Nassar, Ahmed A Zeeneldin, Amany Mohamed Helal, Yahia Mahmoud Ismail, Abeer Mohamed Elsayed, Mohamed A Elbassuiony, Manar M Moneer
BACKGROUND: Epithelial ovarian cancer (EOC) is the commonest malignancy involving the ovaries. Maximum surgical cytoreduction (MCR) followed by adjuvant taxane-platinum chemotherapy are the standard of care treatments. AIMS: To study treatment outcomes of EOC patients that were maximally cyto-reduced and received adjuvant paclitaxel-carboplatin (PC) chemotherapy. MATERIALS AND METHODS: This retrospective cohort study included 174 patients with EOC treated at the Egyptian National Cancer Institute between 2006 and 2010...
2015: Asian Pacific Journal of Cancer Prevention: APJCP
https://www.readbyqxmd.com/read/25281491/chemotherapy-induced-peripheral-neuropathy-and-its-impact-on-health-related-quality-of-life-among-ovarian-cancer-survivors-results-from-the-population-based-profiles-registry
#6
Nicole P M Ezendam, Brenda Pijlman, Celine Bhugwandass, Johannes F M Pruijt, Floortje Mols, M Caroline Vos, Johanna M A Pijnenborg, Lonneke V van de Poll-Franse
OBJECTIVE: This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neuropathy, and its impact on health-related quality of life among ovarian cancer survivors, 2-12 years after diagnosis. METHODS: Women (n=348) diagnosed with ovarian cancer between 2000 and 2010, as registered by the Dutch population-based Eindhoven Cancer Registry, were eligible for participation. A questionnaire, including the EORTC QLQ-C30 and EORTC QLQ-OV28 measures, containing 3 items about neuropathy, was returned by 191 women (55%)...
December 2014: Gynecologic Oncology
https://www.readbyqxmd.com/read/24602386/lower-extremity-edema-in-patients-with-early-ovarian-cancer
#7
REVIEW
Myong Cheol Lim, Jeong Seon Lee, Byung Ho Nam, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park
BACKGROUND: The objective of this study was to investigate clinical manifestations of lower extremity edema (LEE) in early ovarian cancer. METHODS: Patients with early ovarian cancer who underwent staging surgery between January 2001 and December 2010. Medical records for LEE and/or responses to the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) were evaluated. RESULTS: Patients had a median age of 46 years. Twenty-nine patients (40.8%) had past (13 patients, 44...
2014: Journal of Ovarian Research
https://www.readbyqxmd.com/read/23685012/validating-the-m-d-anderson-symptom-inventory-mdasi-for-use-in-patients-with-ovarian-cancer
#8
Mary H Sailors, Diane C Bodurka, Ibrahima Gning, Lois M Ramondetta, Loretta A Williams, Tito R Mendoza, Sonika Agarwal, Charlotte C Sun, Charles S Cleeland
OBJECTIVE: The M. D. Anderson Symptom Inventory (MDASI) captures the severity of common cancer symptoms from the patient's perspective. We describe the validity and sensitivity of a module of the MDASI to be used with patients having ovarian cancer (MDASI-OC). METHODS: Ovarian cancer-specific module items were developed from 14 qualitative patient interviews. 128 patients with invasive epithelial ovarian, peritoneal, or fallopian-tube cancer treated at The University of Texas MD Anderson Cancer Center were recruited...
August 2013: Gynecologic Oncology
https://www.readbyqxmd.com/read/23290163/-interstitial-implantation-of-%C3%A2-%C3%A2-%C3%A2-%C2%B5i-seed-therapy-for-recurrent-ovarian-cancer
#9
Chang-lun Li, Ji-hong Liu, Jin-hua Huang, Yang-kui Gu, Fei Gao, Qi-dan Huang, Ying-ying Hu, Xiong-ying Jiang, Ying-jie Huang
OBJECTIVE: To explore the feasibility, short-term efficacies and complications of computed tomography (CT)-guided ¹²⁵I interstitial implant therapy for recurrent ovarian cancer. METHODS: From October 2009 to November 2010, a total of 25 lesions for 12 patients were diagnosed as recurrent ovarian cancer by positron emission tomography/computed tomography (PET/CT). Among 25 lesions, 21 underwent ¹²⁵I seed implantation. And 4 lesions of liver and spleen in one patient were treated with microwave ablation...
October 23, 2012: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://www.readbyqxmd.com/read/22969845/objective-evaluation-of-the-alleviating-effects-of-goshajinkigan-on-peripheral-neuropathy-induced-by-paclitaxel-carboplatin-therapy-a-multicenter-collaborative-study
#10
Hiroi Kaku, Seisuke Kumagai, Hiroki Onoue, Anna Takada, Tadahiro Shoji, Fumiharu Miura, Akira Yoshizaki, Shinya Sato, Junzo Kigawa, Tsutomu Arai, Shinpei Tsunoda, Eiichiro Tominaga, Daisuke Aoki, Toru Sugiyama
Paclitaxel/carboplatin chemotherapy for cancer (TC therapy) exhibits neurotoxicity and causes peripheral neuropathy at a high frequency, which is difficult to cope with. In this study, we investigated the efficacy of Goshajinkigan, a traditional Japanese herbal medicine, for TC therapy-induced peripheral neuropathy. The subjects included in our study were patients with ovarian or endometrial cancer who underwent TC therapy and developed peripheral neuropathy. The patients were randomly divided into Group A, comprising of 14 patients (vitamin B12 treatment), and Group B, comprising of 15 patients (vitamin B12 + Goshajinkigan treatment)...
January 2012: Experimental and Therapeutic Medicine
https://www.readbyqxmd.com/read/22421769/-assessment-of-health-related-quality-of-life-in-cancer-outpatients-treated-with-chemotherapy
#11
Tomohisa Yokoyama, Yui Kurokawa, Rinako Kani, Emiko Takatori, Shoko Nokiguchi, Yasuyo Suzuki, Hanayo Kawashima, Michiko Uenishi, Miyuki Kawashima, Youichi Osato, Hironobu Miyamatsu, Atsushi Sofuni, Takao Itoi, Norihiko Ikeda, Kazuma Ohyashiki
PURPOSE: Few studies have been conducted to elucidate the health-related quality of life(HR-QOL)of cancer outpatients treated with chemotherapy. In this study, we attempted to determine the physical and psychological distress of cancer outpatients treated with chemotherapy. METHODS: Two-hundred and ninety-six outpatients with various malignancies, including malignant lymphoma, and esophageal, gastric, pancreatic, colon, lung, breast, ovarian, uterine and skin cancers, were investigated using the Japanese version of the M...
March 2012: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://www.readbyqxmd.com/read/21118496/exon-array-analysis-using-re-defined-probe-sets-results-in-reliable-identification-of-alternatively-spliced-genes-in-non-small-cell-lung-cancer
#12
Wolfram Langer, Florian Sohler, Gabriele Leder, Georg Beckmann, Henrik Seidel, Jörn Gröne, Michael Hummel, Anette Sommer
BACKGROUND: Treatment of non-small cell lung cancer with novel targeted therapies is a major unmet clinical need. Alternative splicing is a mechanism which generates diverse protein products and is of functional relevance in cancer. RESULTS: In this study, a genome-wide analysis of the alteration of splicing patterns between lung cancer and normal lung tissue was performed. We generated an exon array data set derived from matched pairs of lung cancer and normal lung tissue including both the adenocarcinoma and the squamous cell carcinoma subtypes...
2010: BMC Genomics
https://www.readbyqxmd.com/read/20797951/predictors-of-self-reported-memory-problems-in-patients-with-ovarian-cancer-who-have-received-chemotherapy
#13
Jamie S Myers, Valmi D Sousa, Heidi S Donovan
PURPOSE/OBJECTIVES: To examine the association between self-report of memory problems and the most commonly reported concurrent symptoms by women with ovarian cancer who have received chemotherapy. DESIGN: Secondary analysis. SETTING: Midwestern university-based school of nursing. SAMPLE: 638 women with ovarian cancer participating in a larger study who had received chemotherapy and 68 women with ovarian cancer who had not received chemotherapy...
September 2010: Oncology Nursing Forum
https://www.readbyqxmd.com/read/20634279/long-term-harm-of-low-preparedness-for-a-wife-s-death-from-cancer-a-population-based-study-of-widowers-4-5-years-after-the-loss
#14
Arna Hauksdóttir, Gunnar Steineck, Carl Johan Fürst, Unnur Valdimarsdóttir
The authors examined the impact of a widower's preparedness before his wife's death from cancer on his risk of long-term morbidity. In a population-based study, 691 (76%) of 907 Swedish men who lost a wife to breast, ovarian, or colon cancer in 2000 or 2001 answered an anonymous questionnaire in 2004 or 2005 measuring preparedness at the time of the wife's death and psychological well-being at follow-up. Men aged 38-61 years with a low degree of preparedness at the time of their spouse's death had increased risk of psychological morbidity and other symptoms, such as anxiety (adjusted relative risk (aRR) = 2...
August 15, 2010: American Journal of Epidemiology
https://www.readbyqxmd.com/read/19048252/breast-cancer-cells-expressing-stem-cell-markers-cd44-cd24-lo-are-eliminated-by-numb-1-peptide-activated-t-cells
#15
Takashi Mine, Satoko Matsueda, Yufeng Li, Hiroshi Tokumitsu, Hui Gao, Cristopher Danes, Kwong-Kwok Wong, Xinhui Wang, Soldano Ferrone, Constantin G Ioannides
Cancer stem cells (CSC) are resistant to chemo- and radiotherapy. To eliminate cells with phenotypic markers of CSC-like we characterized: (1) expression of CD44, CD24, CD133 and MIC-A/B (NKG2 receptors) in breast (MCF7) and ovarian (SK-OV-3) cells resistant to gemcitabine (GEM), paclitaxel (PTX) and 5-fluorouracil (5-FU) and (2) their elimination by Numb- and Notch-peptide activated CTL. The number of cells in all populations with the luminal CSC phenotype [epithelial specific antigen(+) (ESA) CD44(hi) CD24(lo), CD44(hi) CD133(+), and CD133(+) CD24(lo)] increased in drug-resistant MCF7 and SK-OV-3 cells...
August 2009: Cancer Immunology, Immunotherapy: CII
https://www.readbyqxmd.com/read/18433846/cauda-equina-syndrome-due-to-leptomeningeal-carcinomatosis-of-the-ovary
#16
W S Baek, S V Kubba
BACKGROUND: Serous cystadenocarcinoma is the most common malignant ovarian tumor. 85% are associated with extraovarian spread at the time of diagnosis. Cauda equina syndrome due to leptomeningeal ovarian serous cystadenocarcinomatosis is rare. CASE: A 66-year-old female with stage IV ovarian papillary serous cystadenocarcinoma presented with perianal numbness and sphincter dysfunction. On exam she had decreased anal tone with saddle anesthesia. Her MRI did not demonstrate any leptomeningeal involvement...
December 2008: Gynecologic Oncology
https://www.readbyqxmd.com/read/17332928/novel-natural-immunogenic-peptides-from-numb1-and-notch1-proteins-for-cd8-cells-in-ovarian-ascites
#17
Satoshi Ishiyama, Satoko Matsueda, Lovell A Jones, Clay Efferson, Joseph Celestino, Rosemarie Schmandt, Constantin G Ioannides, Naotake Tsuda, David Z Chang
Notch is a plasma membrane receptor involved in the control of cell fate specification and in the maintenance of the balance between proliferation and differentiation in many cell lineages. Disruption of Notch has been implicated in a variety of hematological and solid cancers. Numb is also expressed in many adult mammalian cells. Adult cells divide symmetrically, and Numb is symmetrically partitioned at mitosis. The Numb-mediated regulation of Notch is believed to play a causative role in naturally occurring breast cancers...
April 2007: International Journal of Oncology
https://www.readbyqxmd.com/read/10920970/-a-phase-ii-clinical-study-of-china-made-paclitaxel-in-the-treatment-of-cancer-patients
#18
MULTICENTER STUDY
H Wu, Z Guan, T Lin
OBJECTIVE: To evaluate the efficacy and toxicity of China-made paclitaxel in patients with a variety of advanced malignancies. METHODS: Paclitaxel was administered by i.v. infusion at a dose of 175 mg/m2 in 3-hour every three weeks. All patients received premedication(dexamethasone, diphenhydramine and cimetidine) to prevent allergic reactions. RESULTS: Of 116 patients, 114 patients received 2 to 3 courses of therapy and were evaluable for response...
March 1998: Zhonghua Zhong Liu za Zhi [Chinese Journal of Oncology]
https://www.readbyqxmd.com/read/8521639/-a-case-of-subacute-sensory-neuropathy-associated-with-extraovarian-serous-papillary-adenocarcinoma-of-the-peritoneum
#19
H Ichinose, M Ushiyama, S Tsukahara, T Tsukamoto, S Ikeda, N Yanagisawa
We reported a case of subacute sensory neuropathy. A 78-year-old woman was admitted to Kenwakai Hospital because of progressive numbness in her hands and feet. Four months before admission, numbness and tingling sensations appeared in her hands and feet, and subsequently she felt difficulty in skilled finger movement. On general examination, she was found to have a mass in the right lower abdomen. Neurological examination revealed marked loss of position sense and vibratory sense in the distal extremities, and mild reduction of sensation to pinprick and light touch in the distal extremities...
June 1995: Rinshō Shinkeigaku, Clinical Neurology
https://www.readbyqxmd.com/read/7944492/-a-phase-ii-study-of-bms-181339-in-patients-with-ovarian-cancer-bms-181339-ovarian-cancer-study-group
#20
MULTICENTER STUDY
K Noda, M Ikeda, R Kudo, I Nishiya, A Yajima, K Tanaka, S Kodama, S Nozawa, Y Taketani, Y Terashima
We conducted a multicenter Phase II study of BMS-181339 in patients with ovarian cancer. The facilities participating were 23 in number. The total number of cases registered for the study were 62; 57 of them entered for evaluation in drug efficacy, and 58 cases were evaluable in drug safety. All the cases were previously treated with chemotherapy including platinum-based drugs. The clinical responses of BMS-181339 were as follows: CR, 1 case; PR, 13 cases; MR, 3 cases; NC, 13 cases and PD, 27 cases. The response rate was 24...
October 1994: Gan to Kagaku Ryoho. Cancer & Chemotherapy
keyword
keyword
100815
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"